Orange Book product · Generic (ANDA)
LEVORPHANOL TARTRATE
LEVORPHANOL TARTRATE
At a glance
Jul 20, 2021
Approved
Generic (ANDA)
Application
BX
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 20, 2021
5 yr ago
Today
Pharmaceutical detail
Active ingredient
LEVORPHANOL TARTRATE
Strength
1MG
Dosage form
TABLET
Route
ORAL
TE code
BX
Application
ANDA 213479
Product number
003
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LEVORPHANOL TARTRATE
- 1991LEVO-DROMORANBrand (NDA)
NDA 008719 · VALEANT PHARM INTL
- 1991LEVO-DROMORANBrand (NDA)
NDA 008720 · VALEANT PHARM INTL
- 2021LEVORPHANOL TARTRATEGeneric (ANDA)
ANDA 213906 · SUN PHARM INDS INC
- 2019LEVORPHANOL TARTRATEGeneric (ANDA)
ANDA 212024 · SPECGX LLC
- 2018LEVORPHANOL TARTRATEGeneric (ANDA)
ANDA 211484 · ACERTIS PHARMS
- 2018LEVORPHANOL TARTRATEGeneric (ANDA)
ANDA 074278 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
